Page 18 - De Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China’s Yuanxin Technology nets $465m funding from Tencent, Sequoia, others February 9, 2021 Beijing Yuanxin Technology Co., Ltd, a specialist in digital healthcare and chain pharmacies, has raised 3 billion yuan ($465 million) in a Series E round co-led by existing investors Tencent and Sequoia Capital China. The round attracted a slew of investors from primary and secondary markets, according to a company statement on Tuesday. Existing investors including state-backed CITIC Group’s brokerage firm CITIC Securities, Qiming Venture Partners, Index Capital, and Kunling Capital re-upped in t...

By Reuters Staff 2 Min Read SHANGHAI, Jan 19 (Reuters) - A Chinese mutual fund attracted a record $37 billion worth of investor subscriptions on the first day of sales, state media reported, reflecting Chinese retail fever toward stocks. E Fund Management Co launched the fund on Monday and raised 237 billion yuan ($36.6 billion) in subscription money, nearly 16 times its fundraising cap of 15 billion yuan, official Securities Times reported on Tuesday, citing sales channels. E Fund said official data will be released soon, without giving figures. The demand reflects Beijing’s success in boo...

Fidelity leads $100m Series C round in China-based clinical CRO dMed Source: Volodymyr Hryshchenko/Unsplash Premium dMed Biopharmaceutical, a clinical contract research organisation (CRO) with operations in China and the US, announced on Thursday that it has raised $100 million in a Series C round of financing led by Fidelity Management & Research Company. Continue reading this story with a subscription to DealStreetAsia. Contact us for corporate subscriptions at subs@dealstreetasia.com. Sign up for our newsletter - The Daily Brief Opt out of receiving The...

Regency Centers Invites You to Join Its Fourth Quarter 2020 Earnings Conference Call Regency Centers Invites You to Join Its Fourth Quarter 2020 Earnings Conference Call JACKSONVILLE, Fla., Dec. 16, 2020 — Regency Centers Corporation (The “Company”) (NASDAQ: REG) will announce its Fourth Quarter 2020 earnings results on Thursday, February 11, 2021, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings con...

dMed, a Shangai, China-based clinical CRO, completed a US$100m Series C financing. The round was led by Fidelity Management & Research Company, LLC, with participation from new investors Sequoia Capital China, Kaiser Foundation Hospitals and E Fund, and existing backers Qiming Venture Partners, Lilly Asia Ventures, and Vivo Capital. Led by Founder, Chairman and CEO, Dr. Lingshi Tan, dMed is a full-service Clinical Contract Research Organization (CRO), which provides industry solutions to pharmaceutical and medical device companies in China and across the globe. The company leverages an...